Dec 06, 2019
SK life science to Present Latest Cenobamate Data at the American Epilepsy Society 2019 Annual Meeting
Dec 05, 2019
UCB Presents New Data Demonstrating Commitment to Epilepsy at 2019 American Epilepsy Society Meeting
Dec 04, 2019
Cognizance Biomarkers Initiates Clinical Trial to Confirm Its Test Can Distinguish Epileptic Seizures from Psychogenic Nonepileptic Seizures
Dec 02, 2019
SK Life Science, Inc. Announces FDA Acceptance of IND Application for Anti-Epileptic Drug Candidate SKL24741
Nov 25, 2019
UCB Announces availability of NAYZILAM® (midazolam) Nasal Spray CIV, the first and only nasal rescue treatment for seizure clusters in the U.S.
Nov 21, 2019
FDA approves new treatment for adults with partial-onset seizures
Nov 13, 2019
Results of a Randomized Study of the Safety and Efficacy of Cenobamate in Adults with Uncontrolled Focal Seizures Published in The Lancet Neurology
Nov 05, 2019
CODA Biotherapeutics Announces Series A Extension, Bringing Total Round to $34 Million
Oct 24, 2019
World Federation of Neurology Reveals New Frontiers in Epilepsy Treatment for Children, Pregnant Women and, New Links Between ADHD and Epilepsy at 24th Annual World Congress of Neurology, Dubai, Oct 27 - 31
Oct 22, 2019
Neurelis Announces Three Poster Presentations At The Annual Meeting Of The Child Neurology Society
Oct 21, 2019
Epilepsy Foundation Rolls Out #StaySafeSide to Promote Seizure First Aid
Sep 16, 2019
The Northeast Regional Epilepsy Group's (NEREG) Sixth Annual Conference on Psychogenic Non-Epileptic Seizures (PNES) on October 19, 2019
Aug 26, 2019
Over 99% Of EEG Epileptic Abnormalities Can Be Detected By EEG Systems Without Midline Or Parasagittal Leads
Jul 18, 2019
Mesa Science Associates to Present on Canine Epilepsy at The Kansas City Animal Health Corridor Annual Investors Meeting
Jul 17, 2019
SK life science Expands Support for the J. Kiffin Penry Epilepsy Education Programs to Reach More Healthcare Providers
Jul 15, 2019
Persons With Alzheimer's Disease More Likely To Experience Recurring Epileptic Seizures
Jun 25, 2019
Eisai Presents Data To Assess Seizure Freedom With FYCOMPA® Monotherapy In Newly Diagnosed Or Untreated Patients With Partial Onset Seizures
Jun 24, 2019
Epygenix Therapeutics Submits Investigational New Drug Application for EPX-100 to the U.S. FDA for the Treatment of Patients With Dravet Syndrome
Jun 24, 2019
Study Shows Seizure Freedom for Most Epilepsy Patients with Minimally Invasive Laser Ablation Procedure
Jun 24, 2019
Global Childhood Absence Epilepsy Treatment Market to Witness Strong Growth of Typical Absence Seizure Segment - QYR Consulting